Do you want to read an article? Please log in or register.
Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a metaanalysis
Lung, Respiratory and Thoracic Cancer
Related content
Lung, Respiratory and Thoracic CancerSkin Cancer
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
JAMA Oncol.
Mezquita L, Auclin E, Ferrara R, Charrier M, Remon J, Planchard D, Ponce S, Ares LP, Leroy L, Audigier-Valette C, Felip E, Zerón-Medina J, Garrido P, Brosseau S, Zalcman G, Mazieres J, Caramela C, Lahmar J, Adam J, Chaput N, Soria JC, Besse B
doi: 10.1001/
Lung, Respiratory and Thoracic Cancer
Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer
JAMA Oncol.
Kazandjian D, Gong Y, Keegan P, Pazdur R, Blumenthal GM
doi: 10.1001/jamaoncol.2019.1747.
Lung, Respiratory and Thoracic Cancer
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
JAMA Oncol.
Shankar B, Zhang J, Naqash AR, Forde PM, Feliciano JL, Marrone KA, Ettinger DS, Hann CL, Brahmer JR, Ricciuti B, Owen D, Toi Y, Walker P, Otterson GA, Patel SH, Sugawara S, Naidoo J
doi: 10.1001/jamaoncol.2020.5012.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors
★ 1
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
Eur J Cancer
Skribek M, Rounis K, Afshar S, Grundberg O, Friesland S, Tsakonas G, Ekman S, De Petris L
doi: 10.1016/j.ejca.2020.12.012
Genitourinary CancerLung, Respiratory and Thoracic CancerSkin Cancer
Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
Int J Radiat Oncol Biol Phys.
Chen L, Douglass J, Kleinberg L, Ye X, Marciscano AE, Forde PM, Brahmer J, Lipson E, Sharfman W, Hammers H, Naidoo J, Bettegowda C, Lim M, Redmond KJ
doi: 10.1016/j.ijrobp.2017.11.041.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors : Antibiotics immune checkpoint inhibitors in advanced NSCLC
Cancer Chemother Pharmacol.
Schett A, Rothschild SI, Curioni-Fontecedro A, Krähenbühl S, Früh M, Schmid S, Driessen C, Joerger M
doi: 10.1007/s00280-019-03993-1.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment
Cancer Manag Res.
Diem S, Fässler M, Ali OH, Siano M, Niederer R, Berner F, Roux GA, Ackermann CJ, Schmid S, Güsewell S, Früh M, Flatz L
doi: 10.2147/CMAR.S179767.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Outcome of non-small cell lung cancer patients with brain metastases treated with checkpoint inhibitors
J Thorac Oncol.
Hendriks LEL, Henon C, Auclin E, Mezquita L, Ferrara R, Audigier-Valette C, Mazieres J, Lefebvre C, Rabeau A, Le Moulec S, Cousin S, Duchemann B, le Pechoux C, Botticella A, Ammari S, Gazzah A, Caramella C, Adam J, Lechapt E, Planchard D, de Ruysscher D, Dingemans AM, Besse B
doi: 10.1016/j.jtho.2019.02.009.
RECOMMENDED
Radio-Oncology
Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy
★ 1
Recommended by
Alexander Meisel, Faculty Member
Eur J Cancer.
Schweizer C, Schubert P, Rutzner S, Eckstein M, Haderlein M, Lettmaier S, Semrau S, Gostian AO, Frey B, Gaipl US, Zhou JG, Fietkau R, Hecht M
doi: 10.1016/j.ejca.2020.09.001.Visit the original publication at ncbi.nlm.nih.gov